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Abstract 
 
Infection remains one of the most challenging complications of joint arthroplasty. The 
risk of such infections is higher in revision arthroplasties and in patients who have had 
prior operative procedures on the affected joint.  
 
First generation cephalosporins such as Cephalothin are widely used as the 
prophylactic antibiotic for primary joint arthroplasty procedures, however there are no 
studies which demonstrate their efficacy in revision arthroplasty. 
 
The objectives of this study are to characterise the spectrum and antibiotic 
susceptibility of bacteria isolated from revision hip and knee arthroplasty specimens 
in order to make recommendations regarding the choice of empiric antibiotic therapy 
in the peri-operative period, prior to definitive culture results being available to the 
surgeon. 
 
The microbiology laboratory at The Prince Charles Hospital prospectively collected 
the culture results from revision surgeries on previous hip and knee arthroplasty from 
January 1999 to August 2006. The data was then retrospectively analysed to look at 
the causative organisms and their patterns. 
 
 
Over the period of study there were 147 patients identified who had positive intra-
operative cultures on specimens taken at the time of revision arthroplasty of the hip or 
knee joints. Positive isolates included 195 tissue culture specimens, 43 fluid 
specimens and 10 swabs collections yielding 248 positive isolates. 140 of the isolates 
were obtained from re-operations on hips and 108 from knees.   
 
Gram-positive organisms accounted for the majority of isolates but a wide variety of 
organisms were cultured. Staphylococcus species was the most common group of 
organisms encountered, identified in 52.8% (131) of the 248 positive cultures. 
Coagulase-negative staphylococcus accounted for about two thirds of this group and 
Staphylococcus aureus only about one third. Gram negative organisms accounted for 
about 25% of the isolates. 
 
Of all the specimens isolated, only 38.7% were sensitive to Cephalothin. Only 34.6% 
of the most common isolate (coagulase-negative staphylococcus) was sensitive to 
cephalothin. No gram positive organism vancomycin resistance was detected. 
 
Gentamicin had good activity against Gram-Negative isolates including coliforms and 
Pseudomonas aeruginosa.  
 
The success of antibiotic prophylaxis relates to the susceptibility of bacteria 
encountered during the procedure. The results of this study suggest that Cephalothin 
alone is an inappropriate empiric prophylactic antibiotic regimen for revision hip or 
knee arthroplasty. We recommend that empiric antibiotic prophylaxis for revision hip 
and knee procedures should include vancomycin to cover Gram positive organisms.  
Intravenous gentamicin is a suitable agent for most Gram negative bacteria. Antibiotic 
prophylaxis should be continued for a period of 4 post-operative days until specimen 
isolates remain negative. 
 
